Frost & Sullivan ranks RapidAI's enterprise platform ahead of 96% in the industry
The only enterprise platform connecting imaging to clinical action across the health system
FDA-cleared AI across the body
Used in 2,500+ hospitals globally
Enterprise-grade security & compliance built-in
Close
Browse all deep clinical AI solutions
Explore how RapidAI supports your role
Get to know RapidAI through videos, webinars, case studies, guides and more
Expert guidance and support for every stage of your journey
Explore our mission & story
NEURO NEWS
Recognizing how vital it is that stroke neurosurgeons and neurologists receive timely information about the type of stroke a person is having so they can decide on the best treatment, Atlantic Health System Neuroscience recently introduced a systemwide roll out of a cutting-edge technology called RAPID.
CBS 6 WTVR - RICHMOND
Physicians at Johnston Willis Hospital found a blood clot in Beverly Hill's brain using RAPID, software that quickly analyzes CT and MRI scans to let doctors pinpoint the exact location and severity of a clot.
CBS 58 WDJT - MILWAUKEE
Ascension Wisconsin uses RAPID™ to save an 88-year-old stroke patient's life.
KETTERING HEALTH NETWORK
Kettering Health Network is using RAPID™ software artificial intelligence that can reverse disability in patients with new stroke symptoms.
EMOL
Accidentes cerebrovasculares: Utilizan en Chile revolucionaria tecnología que ayuda a mejorar el pronóstico de pacientes
MDEDGE NEWS
Extend Makes Delayed Thrombolysis Feasible for More U.S. Centers
BUSINESS WIRE
Today at the European Stroke Organization Conference, iSchemaView, the leader in automated cerebrovascular imaging analysis, publicly launched RAPID ASPECTS, a digital imaging solution that assists clinicians in assessing early signs of brain ischemia in stroke.
ASSOCIATION OF AMERICAN MEDICAL COLLEGES
RAPID expands worldwide reach to bring Vietnam the only clinically validated, nextgeneration imaging platform for assessing stroke Menlo Park, Calif.
STANFORD HEALTH CARE
Cindi was treated at Stanford as part of a 38-center clinical trial sponsored by the National Institutes of Health, and led by researchers at the Stanford University School of Medicine.
NEURONEWS INTERNATIONAL
The study results show that endovascular therapy, given alongside standard medical therapy, results in better functional outcome than standard medical therapy alone for ischaemic stroke patients with salvageable tissue on brain imaging, who are treated between six to 16 hours after the patient was last known to be well: the number of patients that needed to be treated to reduce the degree of disability in one patient was just two.
A team of researchers and physicians at Stanford has developed a new software that recently led to the change in stroke guidelines. Certain patients can now be treated up to 24 hours after suffering a stroke.
AHA STROKE JOURNAL
A conversation with Dr. Greg Albers, professor of neurology at Stanford and the principal investigator for DEFUSE 3.